-
Mashup Score: 2
In September 2024, the UN General Assembly will host its second high-level meeting on antimicrobial resistance (AMR). The Global Leaders Group (GLG) on Antimicrobial Resistance has been tasked with supporting preparations for the meeting. On April 4, 2024, the GLG released a new report outlin-ing recommendations to inform discussions at the high-level meeting alongside several proposed targets. An economic study commissioned for the report projected that by 2035, without substantial action on AMR, global life expectancy would drop by 1·8 years, the cost to health care of treating antibiotic resistant infections would reach US$412 billion per year, and productivity losses resulting from AMR would reach $443 billion per year.
Source: www.thelancet.comCategories: General Medicine News, PulmonologyTweet
-
Mashup Score: 15
“Unfortunately, it seems like we’re running out of antibiotic options to treat this infection.”
Source: opmed.doximity.comCategories: General Medicine News, Infectious DiseaseTweet-
In a recently published @doximity op-ed, aspiring infectious diseases physician Michaela Barry, MD, raises the alarm on the #AMR crisis and explains how policy, like the PASTEUR Act can, help. https://t.co/aDm6ZDMI8o
-
-
Mashup Score: 1Program Planner - 3 month(s) ago
Program Planner One fine body�
Source: www.abstractsonline.comCategories: General Medicine News, Cardiology News and JournTweet-
🫁 Join global experts for a symposia session to review novel insights into the pathophysiology of cardiothoracic #AMR that pave the way for new translational approaches: https://t.co/DQNgy039zQ
-
-
Mashup Score: 5
A House of Commons report highlights the challenges facing the further development of phage therapy in the United Kingdom.
Source: www.cidrap.umn.eduCategories: General Medicine News, Infectious DiseaseTweet-
British MPs call for more research into phages to combat drug-resistant microbes #AMR A House of Commons report highlights the challenges facing the further development of phage therapy in the UK https://t.co/lghWNLbeWK https://t.co/NQfisSTqPb
-
-
Mashup Score: 5
A House of Commons report highlights the challenges facing the further development of phage therapy in the United Kingdom.
Source: www.cidrap.umn.eduCategories: General Medicine News, Infectious DiseaseTweet-
British MPs call for more research into phages to combat drug-resistant microbes #AMR A House of Commons report highlights the challenges facing the further development of phage therapy in the UK https://t.co/lghWNLbeWK https://t.co/NQfisSTqPb
-
-
Mashup Score: 10Antimicrobial resistance: MPs call on UK government to maximise potential of bacteriophages - 4 month(s) ago
MPs have called on the UK government to invest in research into bacteriophages as an alternative to antibiotics, including establishing suitable manufacturing facilities in the UK. The House of Commons select committee on science, innovation, and technology said that bacteriophages (“phages”)—specific viruses that target and kill bacteria—could be the answer to the “alarming” rise in antimicrobial resistance to antibiotics. The committee’s detailed report follows an inquiry into evidence on the safety and efficacy of using phages as alternative antimicrobials, as well as assessing the funding and structural challenges in their development.1 Phages have been used as a treatment for over 100 years, but interest in them has increased recently because of their potential in tackling antimicrobial resistance. They have never been licensed for therapeutic use in the UK but are occasionally used as compassionate treatments of last resort in cases of intractable infections. Each phage can targe
Source: www.bmj.comCategories: General Medicine News, General HCPsTweet-
MPs have called on the UK government to invest in research into bacteriophages as an alternative to antibiotics, including establishing suitable manufacturing facilities in the UK #AMR https://t.co/JFeW8ZCHoT
-
-
Mashup Score: 6A just transition for antimicrobial resistance: planning for an equitable and sustainable future with antimicrobial resistance - 5 month(s) ago
Antimicrobial resistance is among the most urgent global health challenges of our time, with an estimated 4·95 million deaths associated with resistant bacteria in 2019.1–3 That microbes develop resistance to antimicrobials is accepted as an evolutionary inevitability for their survival, driven by competition between and among micro-organisms in the natural environment.4 How to reduce the impact of drug resistance in the future is a matter of global concern, considering the consequences that clinically ineffective antimicrobials will have for health care and agricultural systems that have come to rely on these powerful substances.
Source: www.thelancet.comCategories: General Medicine News, General HCPsTweet-
☝️ This includes populations with high risk of infection, patients without access to next-line treatment, carers with few resources, and more. Explore authors’ views on why the global agenda on #AMR should be framed around a “just transition”: https://t.co/vjm7ipUj0V https://t.co/2OUtSg2JHm
-
-
Mashup Score: 40Antibiotic resistant infections and deaths rose in England after pandemic controls ended - 5 month(s) ago
Antibiotic resistance is on the rise in England after a decline during the covid pandemic, and “more dangerous strains of bacteria” are spreading in the community and hospitals, the UK Health Security Agency has warned. National surveillance data unveiled at the UKHSA annual conference in Leeds on 15 November showed that antibiotic resistant infections rose by 4%, from 55 792 in 2021 to 58 224 in 2022. Deaths from severe antibiotic resistant infections also rose over that time, …
Source: www.bmj.comCategories: General Medicine News, General HCPsTweet-
Antibiotic resistance is on the rise in England after a decline during the covid pandemic, and “more dangerous strains of bacteria” are spreading in the community and hospitals, the UK Health Security Agency has warned #AMR https://t.co/s6DhGNXSKM
-
-
Mashup Score: 33Improving antibiotic prescribing for uncomplicated UTIs - 6 month(s) ago
Prescribing patterns in primary care are key drivers of antimicrobial resistance Urinary tract infection (UTI) is a frequent reason for consulting in primary care and is the leading reason for an antibiotic prescription among women.1 Community acquired UTIs are caused predominantly by uropathogenic Escherichia coli, a pathogen with an increasing prevalence of antimicrobial resistance.2 Multiple studies have shown a direct association between antibiotic use and the selection and spread of antimicrobial resistance at the population level,3 including total antibiotic prescribing and proportion of broad spectrum antibiotics prescribed.4,5 Most antibiotics (80-90%) are prescribed outside of hospitals in high income countries. The pattern of antibiotic prescribing in primary care is therefore an important and modifiable driver of antimicrobial resistance. Quinolones have been used extensively for treating uncomplicated UTIs in some countries. This group of antibiotics is a key driver of resi
Source: www.bmj.comCategories: General Medicine News, General Journals & SocietTweet-
The pattern of antibiotic prescribing in primary care is an important and modifiable driver of antimicrobial resistance. A new study shows that antibiotic prescribing behaviour at the practice level can change. What can we learn from this? @arnfinnss #AMR https://t.co/pgcDSb1XzQ
-
-
Mashup Score: 1
Inappropriate antibiotic prescribing in doctors’ offices and other outpatient settings in the U.S. is a widespread problem that accelerates the spread of antibiotic-resistant bacteria. Among privately-insured patients diagnosed with common bacterial infections 31-36% of children received an inappropriate type of antibiotic.
Source: www.pewtrusts.orgCategories: General Medicine News, Latest HeadlinesTweet-
Inappropriate prescribing of antibiotics for pediatric patients with common infections resulted in $74 million in excess health care costs in 2017. #AMR https://t.co/wkWZxcIaZV
-
NEWS: New report outlines cost of inaction on antimicrobial resistance (#AMR) ahead of @UN high-level meeting “We desperately need more national data, so that we can convince governments that AMR is a serious problem" https://t.co/YSq5u9TdwY Written by Talha Burki https://t.co/1wmiDuyCSz